Skip to content

Clinical trials

Completed Observational Respiratory Distress Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Phase: Observational Status: Completed Clear all

248 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20032
20046
20061
20079
20085
20094
20107
201110
20128
201310
201411
201511
201611
201716
201819
201913
202049
202114
202210
202310
202411
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed248

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Clermont-Ferrand6
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)4
Hospital Universitario de Gran Canaria Doctor Negrín4
Policlinico Hospital4
Ain Shams University3
Assistance Publique - Hôpitaux de Paris3
Başakşehir Çam & Sakura City Hospital3
Bicetre Hospital3
Boston Children's Hospital3
European Society of Intensive Care Medicine3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome248
COVID-1934
Acute Lung Injury27
Respiratory Insufficiency26
Pneumonia14
Sepsis12
Coronavirus Infections10
Lung Diseases10
Respiratory Aspiration10
Shock, Septic9

Trials

Showing 1 to 25 of 248. Each trial links to its page on Pharma Observatory.

148 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.